MicroRNA‐122 and cytokeratin‐18 have potential as a biomarkers of drug‐induced liver injury in European and African patients on treatment for mycobacterial infection-Reference-Cited by-同舟云学术

MicroRNA‐122 and cytokeratin‐18 have potential as a biomarkers of drug‐induced liver injury in European and African patients on treatment for mycobacterial infection

Published:2021-01-26 Issue:8 Volume:87 Page:3206-3217
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Rupprechter Sarah A.E.¹,Sloan Derek J.²,Oosthuyzen Wilna¹,Bachmann Till T.³,Hill Adam T.⁴,Dhaliwal Kevin⁴,Templeton Kate³,Matovu Joshua⁵,Sekaggya‐Wiltshire Christine⁵,Dear James W.¹^ORCID

Affiliation:

1. Pharmacology, Therapeutics and Toxicology, Centre for Cardiovascular Science University of Edinburgh, The Queen's Medical Research Institute Edinburgh UK

2. School of Medicine University of St Andrews St Andrews UK

3. Chancellor's Building Edinburgh University/Infection Medicine Edinburgh UK

4. The Queen's Medical Research Institute Edinburgh University/Centre for Inflammation Research Edinburgh UK

5. Infectious Diseases Institute Makerere University College of Health Sciences Kampala Uganda

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14736

Reference34 articles.

1. World Health Organization (WHO).WHO TB Report. WHO Library Cataloguing‐in‐Publication Data World.2019.